Thryve, a Berlin-based B2B health data integration and analytics company, has successfully closed a €4 million Series A funding round. This significant investment will fuel the company’s ambitious plans for international expansion and enhance its capabilities in wearable integration for automated prevention and treatment. The funding round was spearheaded by Belgium’s Capricorn Partners, with additional support from IBB Ventures, CRB Health Tech of Spain, and the German Carma Fund.
Thryve’s unified API is at the forefront of health data integration, allowing health services worldwide to continuously monitor and interpret an individual’s health status through data collected from hundreds of health trackers. This technology is a critical component in providing preventative, automated care accessible at any time, from anywhere.
Thryve’s technology is already widely adopted across Europe, with over 50 million people accessing its solutions through their health insurers for early prevention. Major players like AOK in Germany and Sanitas in Spain rely on Thryve’s technology. Digital therapeutics, such as the leading DiGA-certified Sidekick Rx, use Thryve’s data integration to enhance individualisation and proactive care, particularly in the treatment of conditions like obesity with its product Zanadio.
As industrialised nations grapple with a shrinking workforce and an ageing population, the demand for healthcare far exceeds the available capacity. In Germany alone, over 30% of doctors are set to retire within the next five years, intensifying the strain on the healthcare system. Digital health services, which provide faster and more proactive care, are becoming increasingly favoured by regulators, payers, and consumers alike. With the market growing by over 20% annually and one in two individuals now using a health tracker, Thryve’s technology plays a crucial role in preventing illness through early detection and ensuring continuous access to actionable healthcare insights.
Thryve is committed to advancing the early detection and treatment of diseases through fully automated, home-based solutions powered by health trackers. The newly acquired capital will enable the company to expand its customer base, currently spread across more than 20 countries, and to enhance its analytics and preventative health capabilities. Thryve already offers assessments in areas such as mental, cardiovascular, and metabolic health and plans to broaden its marker coverage and allow customers to run their algorithms within its engine.
Antoine D´Hollander, Investment Director at Capricorn Partners, commented on the investment: “This new funding aligns with our strategy to utilize real-world data for personalized prevention and therapeutics. We are excited about Thryve’s solution, which creates a cost-efficient healthcare ecosystem by integrating data from numerous wearable devices and health apps, facilitating tailored interventions and effective monitoring.”
Thryve’s CEO, Friedrich Lammel, echoed this enthusiasm: “Healthcare is undergoing an epochal transition. I’m convinced that our engine will help the industry make millions of doctor’s visits obsolete and add 20 healthy years to individuals’ lives in the next five years. We’re excited to partner with leading European health funds on this mission and look forward to accelerating our growth.”
